Docebo: Q1 Earnings Insights

Docebo (NASDAQ:DCBO) reported its Q1 earnings results on Thursday, May 11, 2023 at 06:45 AM. Here’s what investors…

Docebo (NASDAQ:DCBO) reported its Q1 earnings results on Thursday, May 11, 2023 at 06:45 AM.

Here’s what investors need to know about the announcement.

Earnings

Docebo beat estimated earnings by 800.0%, reporting an EPS of $0.09 versus an estimate of $0.01.

Revenue was up $9.40 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 3.62% drop in the share price the next day.

Here’s a look at Docebo’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.03 -0.04
EPS Actual 0.10 0.3 0.06 -0.21
Revenue Estimate 39.40M 38.10M 35.00M 29.80M
Revenue Actual 38.95M 36.97M 34.94M 32.05M

To track all earnings releases for Docebo visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Earnings Preview: Lineage Cell Therapeutics

Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.03.

LCTX